These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 4258202
1. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen. Marder VJ. Scand J Haematol Suppl; 1971; 13():21-36. PubMed ID: 4258202 [No Abstract] [Full Text] [Related]
3. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. Marder VJ, Shulman NR, Carroll WR. J Biol Chem; 1969 Apr 25; 244(8):2111-9. PubMed ID: 4238527 [No Abstract] [Full Text] [Related]
4. The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis. Mosesson MW, Finlayson JS, Galanakis DK. J Biol Chem; 1973 Nov 25; 248(22):7913-29. PubMed ID: 4127218 [No Abstract] [Full Text] [Related]
5. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. Plow EF, Hougie C, Edgington TS. J Immunol; 1971 Nov 25; 107(5):1496-500. PubMed ID: 4107365 [No Abstract] [Full Text] [Related]
6. The Tanned Red Cell Hemagglutination Inhibition Immunoassay and purified fibrinogen degradation products. Donati MB, Molla A, Vermylen J. Scand J Haematol Suppl; 1971 Nov 25; 13():91-9. PubMed ID: 4258208 [No Abstract] [Full Text] [Related]
12. Isolation and characterization of the clottable low molecular weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4. Sherman LA, Mosesson MW, Sherry S. Biochemistry; 1969 Apr 31; 8(4):1515-23. PubMed ID: 4241001 [No Abstract] [Full Text] [Related]
13. Characterisation of large fragments rich in disulphide bridges from CNBr-treated products of exhaustive proteolysis of fibrinogen by plasmin. Dudek-Wojciechowska GA, Kloczewiak M, Latallo ZS, Kopeć M. Biochim Biophys Acta; 1973 Feb 21; 295(2):536-42. PubMed ID: 4266974 [No Abstract] [Full Text] [Related]
14. Nature of the high molecular weight fraction of fibrinolytic digests of human fibrinogen. Jamieson GA, Gaffney PJ. Biochim Biophys Acta; 1968 Jan 22; 154(1):96-109. PubMed ID: 4230213 [No Abstract] [Full Text] [Related]
16. FURTHER STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN AND PLASMIN. ROBBINS KC, SUMMARIA L, ELWYN D, BARLOW GH. J Biol Chem; 1965 Jan 16; 240():541-50. PubMed ID: 14253466 [No Abstract] [Full Text] [Related]
17. Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer. Smith GF, Bang NU. Biochemistry; 1972 Aug 01; 11(16):2958-66. PubMed ID: 4261258 [No Abstract] [Full Text] [Related]
18. Platelet fibrinogen. Identity and initial observations on the mode of its degradation by plasmin. James HL, Bradford HR, Ganguly P. Biochim Biophys Acta; 1975 Mar 28; 386(1):209-20. PubMed ID: 236019 [Abstract] [Full Text] [Related]
19. Effects of plasmin on human factor VIII (AHF). Pasquini R, Hershgold EJ. Blood; 1973 Jan 28; 41(1):105-11. PubMed ID: 4118107 [No Abstract] [Full Text] [Related]
20. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum. Gormsen J, Feddersen C, Clemmensen I, Andersen RB. Scand J Haematol; 1972 Jan 28; 9(6):577-86. PubMed ID: 4118846 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]